phenylacetic acid has been researched along with Thyroid Neoplasms in 3 studies
phenylacetic acid : A monocarboxylic acid that is toluene in which one of the hydrogens of the methyl group has been replaced by a carboxy group.
Thyroid Neoplasms: Tumors or cancer of the THYROID GLAND.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Some thyroid cancers are or become dedifferentiated, and they become refractory to efficacy-proven conventional therapies such as radioiodine ablation therapy and thyrotropin (TSH)-suppressive therapy." | 2.42 | Redifferentiation therapy for thyroid cancer. ( Clark, OH; Park, JW, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Park, JW | 1 |
| Clark, OH | 3 |
| Kebebew, E | 1 |
| Wong, MG | 2 |
| Siperstein, AE | 1 |
| Duh, QY | 2 |
| Eigelberger, MS | 1 |
1 review available for phenylacetic acid and Thyroid Neoplasms
| Article | Year |
|---|---|
Redifferentiation therapy for thyroid cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Cell Transformation, Neoplastic; | 2004 |
2 other studies available for phenylacetic acid and Thyroid Neoplasms
| Article | Year |
|---|---|
Phenylacetate inhibits growth and vascular endothelial growth factor secretion in human thyroid carcinoma cells and modulates their differentiated function.
Topics: Antineoplastic Agents; Cell Differentiation; Cell Division; Endothelial Growth Factors; Humans; Lymp | 1999 |
Phenylacetate enhances the antiproliferative effect of retinoic acid in follicular thyroid cancer.
Topics: Antineoplastic Agents; Cell Division; Dose-Response Relationship, Drug; Drug Synergism; Humans; Phen | 2001 |